Anemia, Sickle Cell: all 1,125 studies
Page 8 of 12. Open to participants first (238), then studies with results posted, then the rest; newest registration first within each.
- Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment OptionsNo longer availableNCT03943615
- Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant TransplantActive, not recruitingNCT03924401Phase 2
- Combined Use of a Respiratory Broad Panel Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Hospitalized Sickle-cell Adults With Acute Chest Syndrome.CompletedNCT03919266Not applicable
- Hemoglobin Desaturation in Sickle Cell DiseaseCompletedNCT03908385
- Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)CompletedNCT03904134Not applicable
- Endothelial Monocyte-activating Polypeptide-II in Egyptian Sickle PatientsCompletedNCT03903133Phase 4
- Sickle Cell Pain: Intervention With Capsaicin ExposureCompletedNCT03899246Phase 1
- Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific ProductsTerminatedNCT03886753
- Collect of Cord Blood From Subjects at Risk for Sickle Cell Disease, for the Purpose of Laboratory ResearchCompletedNCT03876821
- A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease PatientsCompletedNCT03815695Phase 1
- Defibrotide in Sickle Cell Disease-Related Acute Chest SyndromeCompletedNCT03805581Phase 2
- Hydroxyurea Optimization Through Precision StudyCompletedNCT03789591Phase 3
- Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2CompletedNCT03758950Phase 2
- Sleep Apnea in Sickle Cell DiseaseTerminatedNCT03753854Not applicable
- Rifaximin to Modify the Disease Course in Sickle Cell DiseaseStatus unknownNCT03719729Phase 2
- Cerebrovascular Reserve and White Matter Disease in Patients with Chronic AnemiaCompletedNCT03715972
- Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical ResearchCompletedNCT03709303
- Exploring Adherence Monitoring in Sickle Cell DiseaseActive, not recruitingNCT03708731
- Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in ChildrenCompletedNCT03682211Phase 4
- Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control TrialStatus unknownNCT03666806Phase 2/3
- Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell DiseaseActive, not recruitingNCT03664830Phase 1
- Early Check: Expanded Screening in NewbornsActive, not recruitingNCT03655223
- Sickle Cell Pro-Inflammatory Response to Interval Training StudyCompletedNCT03653676
- A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell DiseaseCompletedNCT03653247Phase 1/2
- Community Health Workers and mHealth for Sickle Cell Disease CareCompletedNCT03648710Not applicable
- Hydroxyurea and TransfusionCompletedNCT03644953Phase 2
- Music Therapy in Sickle Cell Disease Vaso-occlusive CrisisStatus unknownNCT03639805Not applicable
- Nutritional Outcomes After Vitamin A Supplementation in Subjects With SCDCompletedNCT03632876Not applicable
- Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell DiseaseCompletedNCT03621826
- Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource SettingsStatus unknownNCT03619798
- Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant PatientsCompletedNCT03609840
- Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant PatientsCompletedNCT03609827
- Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)CompletedNCT03609814
- Central Nervous System Vascular Changes in Adult Sickle Cell Disease and the Effect of Treatment With SimvastatinStatus unknownNCT03599609Phase 1/2
- Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell DiseaseTerminatedNCT03577691Not applicable
- Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary HypertensionCompletedNCT03572036
- MUSic Therapy to Improve Quality Of Life in Sickle Cell Disease (MUSIQOLS)CompletedNCT03556657Not applicable
- Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS)CompletedNCT03528434Not applicable
- PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4)CompletedNCT03492931Phase 1
- Stigma, Self-management, & Quality of Life in SCDCompletedNCT03488264
- Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest ImagingCompletedNCT03478917
- Transillumination Device for Peripheral Intravenous Placement in Patients With Sickle Cell Disease (PERFID)CompletedNCT03477552Not applicable
- Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell TransplantCompletedNCT03458897Not applicable
- Predictors and Outcomes in Patients With Sickle Cell DiseaseCompletedNCT03431935
- Stem Cell Transplant in Patients With Severe Sickle Cell DiseaseTerminatedNCT03421756Early Phase 1
- Vitamin D Supplementation in Children With Sickle Cell DiseaseCompletedNCT03417947Phase 3
- Transfusion in Sickle Cell Disease: Screening of Sickle Cell Disease Trait in Blood DonorsCompletedNCT03405688Not applicable
- Transfusion in Sickle Cell Disease: Risk Factors for AlloimmunizationCompletedNCT03405402Not applicable
- Risk Factors for Allo-immunization in Sickle Cell DiseaseWithdrawnNCT03401125
- Transfusion Treatment in Patients With SCDCompletedNCT03397017
- HRV-B for Symptom Management in Sickle Cell PatientsCompletedNCT03383913Not applicable
- Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)CompletedNCT03380351
- Epidemiology of Silent and Overt Strokes in Sickle Cell DiseaseActive, not recruitingNCT03376893
- Implication of the Oxydative Stress in the Pathophysiology of Sickle Cell Anemia:CompletedNCT03368924Not applicable
- Epidemiology and Pathophysiological Mechanisms of HTAP in SS and SC Children in Martinique and Guadeloupe.CompletedNCT03368261Not applicable
- Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant DiseasesTerminatedNCT03367546Phase 2
- Substudy of CADRE: for People With Extreme Phenotype: BIOCADREStatus unknownNCT03352986
- Re-Aiming at Hydroxyurea Adherence for Sickle Cell With mHealthCompletedNCT03344900
- Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell DiseaseWithdrawnNCT03298399Phase 1
- Zinc Supplementation in Children With Sickle Cell Disease in Western KenyaCompletedNCT03293641Not applicable
- Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and GeneticsStatus unknownNCT03288012
- Gene Transfer for Sickle Cell DiseaseActive, not recruitingNCT03282656Phase 1
- Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell DiseaseWithdrawnNCT03279094Phase 1
- Kidney Function in Sickle Cell AnemiaActive, not recruitingNCT03277547
- Disseminating NIH Evidence Based Sickle Cell Recommendations in North CarolinaCompletedNCT03253211
- sPLA2 in EBC During Acute Chest SyndromeCompletedNCT03250585
- A Blood Stem Cell Transplant for Sickle Cell DiseaseActive, not recruitingNCT03249831Phase 1
- A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCDStatus unknownNCT03247218Phase 2
- Muscle Function and Its Biological and Physiological Determinants in Sickle Cell DiseaseCompletedNCT03243812Not applicable
- HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell DiseaseCompletedNCT03240731Phase 2
- Evaluation of Knowledge Among Adolescents With Sickle Cell Disease.CompletedNCT03235011
- BEATS 2: Music Therapy in Sickle CellCompletedNCT03233269Not applicable
- Sickle Cell Disease (SCD) Decision AidCompletedNCT03224429Not applicable
- A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCTCompletedNCT03176849Phase 4
- Examining the Knowledge, Attitudes, and Beliefs of Sickle Cell Disease Patients, Parents of Patients With Sickle Cell Disease, and Providers Towards the Integration of CRISPR in Clinical CareCompletedNCT03167450
- Sleep and Pain in Sickle Cell DiseaseCompletedNCT03150433Not applicable
- A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell DiseaseTerminatedNCT03132324Phase 1
- Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic AreasCompletedNCT03128515Phase 3
- A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are AdministeredCompletedNCT03126695Phase 1
- Quality of Care of Children With Sickle Cell Disease (SCD) Screened at Birth in FranceCompletedNCT03119922
- Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytoseStatus unknownNCT03114137
- Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization.CompletedNCT03111589Not applicable
- Acute Kidney Injury in Patients With Sickle Cell DiseaseCompletedNCT03105271
- A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase ICompletedNCT03069430
- Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell CrisisStatus unknownNCT03062501Phase 2
- Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD)WithdrawnNCT03055234Phase 3
- Pathophysiology of Acute Pain in Patients With Sickle Cell DiseaseCompletedNCT03049475
- New Hemolysis Parameters in Sickle Cell DiseaseStatus unknownNCT03040908
- Improving Sickle Cell Disease (SCD) Care Using Web-based GuidelinesCompletedNCT03037021
- Computerized Cognitive Behavioral Therapy Assisted Life Management for Pain in Sickle Cell DiseaseCompletedNCT03029468Not applicable
- Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth OutcomeStatus unknownNCT03027258Not applicable
- A Phase Ib Study of NVX-508 in Sickle Cell DiseaseWithdrawnNCT03013426Phase 1
- Vitamin D3 in Patients With Sickle Cell DiseaseCompletedNCT03012555
- A Pilot Study of Fecal Microbiome and Neutrophil Cellular Adhesion Molecules in Patients With Sickle Cell Disease (SCD)Status unknownNCT03007849
- SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell PainCompletedNCT03006718Not applicable
- A Study of IMR-687 in Healthy Adult VolunteersCompletedNCT02998450Phase 1
- Hydoxyurea Exposure in Lactation A Pharmacokinetics Study (HELPS)CompletedNCT02990598
- Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell DiseaseCompletedNCT02989701Phase 1
- Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell DiseaseCompletedNCT02987725Not applicable
- Fetal Hemoglobin Induction Treatment MetforminCompletedNCT02981329Early Phase 1